Zobrazeno 1 - 4
of 4
pro vyhledávání: '"B Y H, Thong"'
Autor:
S. Ingen-Housz-Oro, V. Schmidt, M. M. Ameri, R. Abe, A. Brassard, A. Mostaghimi, A. S. Paller, A. Romano, B. Didona, B. H. Kaffenberger, B. Ben Said, B. Y. H. Thong, B. Ramsay, E. Brezinova, B. Milpied, C. G. Mortz, C. Y. Chu, C. Sotozono, J. Gueudry, D. G. Fortune, S. M. Dridi, D. Tartar, G. Do-Pham, E. Gabison, E. J. Phillips, F. Lewis, C. Salavastru, B. Horvath, J. Dart, J. Setterfield, J. Newman, J. T. Schulz, A. Delcampe, K. Brockow, L. Seminario-Vidal, L. Jörg, M. P. Watson, M. Gonçalo, M. Lucas, M. Torres, M. H. Noe, N. Hama, N. H. Shear, P. O’Reilly, P. Wolkenstein, P. Romanelli, R. P. Dodiuk-Gad, R. G. Micheletti, G. S. Tiplica, R. Sheridan, S. Rauz, S. Ahmad, S. L. Chua, T. H. Flynn, W. Pichler, S. T. Le, E. Maverakis, S. Walsh, L. E. French, M. C. Brüggen
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Long-term sequelae are frequent and often disabling after epidermal necrolysis (Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)). However, consensus on the modalities of management of these sequelae is lacking.
Externí odkaz:
https://doaj.org/article/03fab2d6e5c44c33a299e7696bc863e7
Publikováno v:
APLAR Journal of Rheumatology. 9:157-160
Anti-tumour necrosis factor-α (anti-TNF-α) agents are biologic disease-modifying antirheumatic drugs (DMARDs) used in the treatment of moderate to severe rheumatoid arthritis (RA). We describe the demographic and therapeutic profiles of 22 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bcfb59e97e6cd90b58075285d9e17ae
https://doi.org/10.1111/j.1479-8077.2006.00191.x
https://doi.org/10.1111/j.1479-8077.2006.00191.x
Autor:
K P, Leong, E Y Y, Chong, K O, Kong, S P, Chan, B Y H, Thong, T Y, Lian, H H, Chng, E T, Koh, C L, Teh, T C, Lau, W G, Law, Y K, Cheng, H, Badsha, L C, Chew, W H, Yong, H S, Howe, Justina, Tan
Publikováno v:
Lupus. 19(1)
Patients with systemic lupus erythematosus often assess their disease activity differently from their physicians. We studied the factors associated with this discordance. The data provided by 534 systemic lupus erythematosus patients were analyzed. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe533352626e7f620a49214a4fc44df
https://pubmed.ncbi.nlm.nih.gov/19880553
https://pubmed.ncbi.nlm.nih.gov/19880553
Autor:
H. S. Howe, P. L. Cheung, K. O. Kong, H. Badsha, B. Y. H. Thong, K. P. Leong, E. T. Koh, T. Y. Lian, Y. K. Cheng, S. Lam, D. Teo, T. C. Lau, B. P. Leung
Publikováno v:
Rheumatology; Jan2005, Vol. 44 Issue 1, p51-54, 4p